Eli Lilly is making it cheaper and easier to buy high-doses of blockbuster weight loss drug Zepbound
This new AI tool at the Food and Drug Administration promises to speed up scientific reviews
Hims & Hers stock price soars after partnership with Novo Nordisk to offer weight-loss drug Wegovy
2025 drug price rise: Pharma companies plan to make more than 250 medicines more expensive
Cassava Sciences update: SAVA stock price collapses after much-criticized Alzheimer’s drug flops
Why Ozempic, Zepbound, and other weight-loss drug dupes carry risks
WeightWatchers stock price skyrockets on news that it will offer a compounded GLP-1 weight-loss drug like Wegovy
Hims & Hers Health stock tanks after FDA says competitor Eli Lilly’s weight-loss drug shortage is over
FTC goes after drug middlemen for allegedly jacking up insulin prices
Novo Nordisk shares take a hit after a report revealed Eli Lilly’s better weight loss drug
FDA approves a second Alzheimer’s drug shown to delay cognitive decline
Psychedelic drug MDMA could be ‘a new avenue of treatment’ as FDA begins its first-ever review
Forget Ozempic: There could be an even more effective weight-loss drug on the way
Marijuana could share the same status as steroids, in a historic shift in U.S. drug policy
Weight-loss drug startup Metsera wants to take on Novo and Lilly. Here’s what you need to know
Eli Lilly’s weight-loss drug Zepbound might help cure your sleep apnea
Wegovy is no longer just a weight-loss drug
Frankly, CVS’s simplified drug pricing plan is more confusing than ever
Why is Novo Nordisk’s stock up? Here’s what to know about its weight-loss drug Wegovy’s heart disease trials
Now Ozempic could cure drug addiction as well as obesity
FTC asks court to hold Martin Shkreli in contempt for launching new drug company
The first CRISPR gene-editing drug is coming—possibly as soon as next year
